Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 19238, Suchdauer: 0.92s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Blood Cancer Clinical Trials Long-term Follow-up Using Integrated Healthcare Systems Data (BLISS): protocol for a data-linkage study integrating randomised clinical trials with national healthcare systems data

von Sarah Brown ; David A Cairns ; Gordon Cook ; et al.

BMJ Open, Vol 16, Iss 5 (2026)

Schlagworte: Medicine
- View full text via DOI
Merkliste

2
Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data

von Martin Kortüm ; Sebastian Theurich ; James Farrell ; et al.

BMC Cancer, Vol 25, Iss 1, Pp 1-10 (2025)

Schlagworte: Composite endpoint; Symptomatic progression-free survival; Patient-reported outcomes; Progression; Systematic literature review; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

3
Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based study

von Eve Roman ; Timothy Bagguley ; Simon Crouch ; et al.

Haematologica, Vol 999, Iss 1 (2026)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

4
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform

von Adrian Mosquera Orgueira ; Marta Sonia Gonzalez Perez ; Mattia D'Agostino ; et al.

HemaSphere, Vol 9, Iss 10, Pp n/a-n/a (2025)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

5
Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma Network

von Grigoris Gerotziafas ; Despina Fotiou ; Inger Nijhof ; et al.

HemaSphere, Vol 9, Iss 8, Pp n/a-n/a (2025)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

6
Artificial intelligence methods applied to longitudinal data from electronic health records for prediction of cancer: a scoping review

von Victoria Moglia ; Owen Johnson ; Gordon Cook ; et al.

BMC Medical Research Methodology, Vol 25, Iss 1, Pp 1-17 (2025)

Schlagworte: Machine learning; Health data; Longitudinal data; Cancer; Time-series; Temporal; Medicine (General); R5-920
- View full text via DOI
Merkliste

7
The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health Service

von Rakesh Popat ; Supratik Basu ; Sarah Henshaw ; et al.

eJHaem, Vol 5, Iss 6, Pp 1133-1143 (2024)

Schlagworte: B‐cell maturation antigen; bispecific antibodies; Delphi study; multiple myeloma; United Kingdom; Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

8
Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK’s Haematological Malignancy Research Network

von Alexandra Smith ; Timothy Bagguley ; Eve Roman ; et al.

Haematologica, Vol 999, Iss 1 (2025)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

9
Influence of multiple trauma on the effect of transfusion strategies in patients with traumatic brain injury: a sub-study of the HEMOTION trial

von Bouras, Marwan ; Lauzier, François ; Fergusson, Dean A. ; et al.

Intensive Care Medicine. 52(2):211-229
- Zum Volltext (via ReDI)
Merkliste

10
Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study

von Sam Keaveney ; Alina Dragan ; Mihaela Rata ; et al.

Insights into Imaging, Vol 14, Iss 1, Pp 1-14 (2023)

Schlagworte: Whole-body MRI; Myeloma; Multi-centre trial; Quality control; Medical physics. Medical radiology. Nuclear medicine; R895-920
- View full text via DOI
Merkliste

11
A comparison of peripheral blood stem cell collection outcomes for multiple myeloma; mobilization matters in the era of IMiD induction

von Thea Chandler ; Christopher Parrish ; Marina Karakantza ; et al.

eJHaem, Vol 4, Iss 3, Pp 625-630 (2023)

Schlagworte: myeloma; stem cell mobilization/homing; stem cell transplantation; Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

12
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic

von Jonathan Carmichael ; Frances Seymour ; Graham McIlroy ; et al.

Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

13
What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial

von Judith Behrens ; Gill Gaskin ; Neil Iggo ; et al.

eJHaem, Vol 4, Iss 1, Pp 246-250 (2023)

Schlagworte: free light chains; myeloma; plasma exchange; renal failure; Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

14
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review

von Hira Mian ; Arleigh McCurdy ; Smith Giri ; et al.

Blood Cancer Journal, Vol 13, Iss 1, Pp 1-13 (2023)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

15
Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results

von Holger W. Auner ; Sarah R. Brown ; Katrina Walker ; et al.

Blood Cancer Journal, Vol 12, Iss 4, Pp 1-8 (2022)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

16
Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry

von Adam Irving ; Dennis Petrie ; Anthony Harris ; et al.

PLoS ONE, Vol 19, Iss 8 (2024)

Schlagworte: Medicine; Science
- Zum Volltext in DOAJ
Merkliste

17
Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma

von Gaurav Agarwal ; Sally Moore ; Ross Sadler ; et al.

Haematologica, Vol 109, Iss 6 (2024)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

18
Mapping the genetic landscape across 14 psychiatric disorders

von Grotzinger, Andrew D. ; Werme, Josefin ; Peyrot, Wouter J. ; et al.

Nature: International weekly journal of science. 649(8096):406-415
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

19
A Post-Market Economic Evaluation of Bortezomib, Lenalidomide and Dexamethasone Versus Pre-funding Standard of Care for Newly Diagnosed Multiple Myeloma Using Registry Data

von Irving, Adam ; Petrie, Dennis ; Harris, Anthony ; et al.

PharmacoEconomics. 44(1):83-95
- Zum Volltext (via ReDI)
Merkliste

20
Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI TrialResearch in context

von John R. Jones ; David A. Cairns ; Tom Menzies ; et al.

EClinicalMedicine, Vol 62, Iss , Pp 102099- (2023)

Schlagworte: Myeloma; Lenalidomide; Lenalidomide maintenance; Second primary malignancy; SPM; Transplant eligible; Medicine (General); R5-920
- View full text via DOI
Merkliste

21
Assessing clinical and cost effectiveness of total versus partial knee replacement (TOPKAT): 10-year follow-up of a multicentre, randomised controlled trial

von Barker, Karen ; Murray, Gordon ; Simpson, Hamish ; et al.

In The Lancet Rheumatology February 2026 8(2):e116-e126
- View full text via DOI
Merkliste

22
Understanding Cross-System Transitions from Head Start to Kindergarten: A Comparative Cross Case Study of Head Start and K-12 Partnerships. OPRE Report 2023-247

von Administration for Children and Families (DHHS), Office of Planning, Research and Evaluation (OPRE) ; NORC at the University of Chicago ; Child Trends ; et al.

Office of Planning, Research and Evaluation. 2023.

Schlagworte: Social Services; Federal Programs; Low Income Students; Transitional Programs; Early Childhood Education; Elementary Schools; School Districts; Partnerships in Education; Preschool Teachers; Kindergarten; Administrators; Leadership; School Community Relationship; Educational Strategies; Educational Practices; School Readiness; Parent Attitudes; Administrator Attitudes; Teacher Attitudes; Elementary Secondary Education
- Zum Volltext in ERIC
Merkliste

23
The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor

von Samantha Hinsley ; Katrina Walker ; Debbie Sherratt ; et al.

Trials, Vol 21, Iss 1, Pp 1-11 (2020)

Schlagworte: Medicine (General); R5-920
- View full text via DOI
Merkliste

24
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providers

von Gordon Cook ; John Ashcroft ; Mariana Fernandez ; et al.

Frontiers in Oncology, Vol 13 (2023)

Schlagworte: daratumumab; intravenous; multiple myeloma; subcutaneous; quality of life; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

25
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial

von Roger Owen ; Mark Cook ; David Meads ; et al.

BMJ Open, Vol 12, Iss 11 (2022)

Schlagworte: Medicine
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag